Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia

Exclusion Criteria

• •Inability or unwillingness to provide consent.
• •Antecedent or concurrent serious medical illness.
• •Clinically unstable medical disease, including cardiovascular, hepatic insufficiency, severe renal impairment, gastrointestinal, pulmonary, metabolic, endocrine, obesity or other systemic disease.
• •History of seizures, excluding febrile seizures in childhood.
• •Patients requiring treatment with any drug which might obscure the action of the study treatment.
• •Female patients who are either pregnant or lactating.
• •Clinically significant laboratory abnormalities in the last year on CBC or TSH tests.
• •Judged clinically to be at suicidal risk (defined as having active suicidal ideation, intent or plan, or a serious suicide attempt within the past 6 months, or a baseline CDRS-R suicide score of \>3).
• •Hospitalized within the last 3 months
• •Greater than 1 year outside appropriate age/grade level
• •Pacemaker
• •Cerebral aneurysm clip
• •Cochlear implant
• •Metal fragments lodged within the eye or braces
• •Claustrophobia
• •Necessity of sedation (no sedation will be given).
• •History of loss of consciousness \> 10 minutes in duration
• •Allergy to seafood.